Serum Institute seeks DCGI nod for clinical trials of COVID-19 vaccine COVOVAX
Jan 30, 2021
New Delhi [India], January 30 : Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by...